JasonLamarAldredMD

Neurology • Spokane, WA

Movement Disorder, Neurophysiology, Vascular Neurology

Selkirk Neurology, PLLC

Join to view full profile

Dr. Aldred is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Aldred's full profile

Already have an account?

Office
610 S Sherman St
Ste 201
Spokane, WA 99202
Phone+1 509-473-0885

Fax+1 509-795-0895
Is this information wrong?

Education & Training

Oregon Health & Science UniversityFellowship, Vascular Neurology, 2007 - 2009
Oregon Health & Science UniversityChief Residency, Neurology, 2006 - 2007
Oregon Health & Science UniversityResidency, Neurology, 2003 - 2007
University of Tennessee Health Science Center College of MedicineClass of 2003
University of TennesseeBA, Latin, Greek, Biochemistry, 1999

Certifications & Licensure

OR State Medical License 2006 - Present
WA State Medical License 2014 - 2026
AZ State Medical License 2023 - 2025
MT State Medical License 2015 - 2025
ID State Medical License 2019 - 2024
WI State Medical License 2009 - 2023
IA State Medical License 2010 - 2017
MN State Medical License 2010 - 2016
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Vascular Neurology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
AAN Resident Scholarship to Annual Meeting 2007
Dr. John H. and Marjorie Burkhart Medical Education Scholarship 2002
Roan Scholarship Award for Medicine 2001
Eta Sigma Phi – NaUonal Honor Society for Classical Studies 1997
Haines-Morris Award for scholarship in Classics 1997
Haines-Morris Award for Archeological Study in Greece 1997
Phi Beta Kappa – Undergraduate Honor Society
Join now to see all

Clinical Trials

High and Low Dose Treatment of Carbidopa in Parkinson's Disease Start of enrollment: 2008 Aug 01
Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes Start of enrollment: 2014 Mar 01
Completed
Not Applicable
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease Start of enrollment: 2015 Jul 01
Completed
Phase 1
A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis Start of enrollment: 2016 Dec 31
Completed
Phase 2
A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness Start of enrollment: 2017 Jan 01
Completed
Phase 2
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease Start of enrollment: 2018 Jan 10
Terminated
Phase 2
Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression Start of enrollment: 2018 Mar 09
Completed
Phase 2
Study to Evaluate DNL201 in Subjects With Parkinson's Disease Start of enrollment: 2018 Dec 04
Completed
Phase 1
A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD) Start of enrollment: 2019 Apr 29
Completed
Phase 3
Rostock International Parkinson's Disease Study (ROPAD) Start of enrollment: 2019 May 30
Recruiting
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease Start of enrollment: 2019 Aug 12
Active, not recruiting
Phase 1
A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease Start of enrollment: 2020 Mar 03
Withdrawn
Phase 1
Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine Start of enrollment: 2019 Oct 23
Terminated
Phase 2
Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations Start of enrollment: 2019 Dec 02
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.
Fung, V., Aldred, J., Arroyo, M., Bergquist, F., Boon, A., Bouchard, M., Bray, S., Dhanani, S., Facheris, M., Fisseha, N., Freire-Alvarez, E., Hauser, R., Jeong, A., J...> ;Clinical Parkinsonism & Related Disorders. 2024 Jan 1
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K Ray Chaudhuri,...> ;Neurology and Therapy. 2023 Dec 1
3 citations
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K Ray Chaudhuri,...> ;Neurology and Therapy. 2023 Dec 1
2 citations
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year Results.
K Ray Chaudhuri, Norbert Kovács, Francesco E Pontieri, Jason Aldred, Paul Bourgeois, Thomas L Davis, Esther Cubo, Marieta Anca-Herschkovitsch, Robert Iansek, Mustafa S...> ;Journal of Parkinson's Disease. 2023 Jan 1
Long-term results of carbidopa/levodopa enteral suspension across the day in advanced Parkinson's disease: Post-hoc analyses from a large 54-week trial.
Rajesh Pahwa, Jason Aldred, Aristide Merola, Niodita Gupta, Emi Terasawa, Viviana Garcia-Horton, David R Steffen, Prasanna L Kandukuri, Yanjun Bao, Omar Ladhani, Conni...> ;Clinical Parkinsonism & Related Disorders. 2023 Jan 1
11 citations
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, p...
Michael J Soileau, Jason Aldred, Kumar Budur, Nahome Fisseha, Victor Sc Fung, Anna Jeong, Thomas E Kimber, Kevin Klos, Irene Litvan, Daniel O'Neill, Weining Z Robieson...> ;The Lancet. Neurology. 2022 Dec 1
1 citations
Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson's Disease: Clinical Tri...
Rajesh Pahwa, Jason Aldred, Niodita Gupta, Emi Terasawa, Viviana Garcia-Horton, David R Steffen, Prasanna L Kandukuri, Vivek S Chaudhari, Yash J Jalundhwala, Yanjun Ba...> ;Neurology and Therapy. 2022 Jun 1
6 citations
Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel.
Norbert Kovács, Lars Bergmann, Marieta Anca-Herschkovitsch, Esther Cubo, Thomas L Davis, Robert Iansek, Mustafa S Siddiqui, Mihaela Simu, David G Standaert, K Ray Chau...> ;Journal of Parkinson's Disease. 2022 Jan 1
20 citations
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease.
David G. Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, Paul Bourgeois, Thomas L. Davis, Robert Iansek, Norbert Kovács, Francesco E. Pontieri, Mustafa S. Siddiq...> ;Movement Disorders Clinical Practice. 2021 Sep 12
33 citations
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review
Angelo Antonini, Per Odin, Rajesh Pahwa, Jason Aldred, Ali Alobaidi, Yash J. Jalundhwala, Pavnit Kukreja, Lars Bergmann, Sushmitha Inguva, Yanjun Bao, K. Ray Chaudhuri> ;Advances in Therapy. 2021 May 20
26 citations
Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE.
Jason Aldred, Marieta Anca-Herschkovitsch, Angelo Antonini, Ovidiu Bajenaru, Lars Bergmann, Paul Bourgeois, Esther Cubo, Thomas L. Davis, Robert Iansek, Norbert Kovács...> ;Neurodegenerative Disease Management. 2020 Sep 2
8 citations
An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson's Disease and Depression.
Daryl DeKarske, Gustavo Alva, Jason L. Aldred, Bruce Coate, Marc Cantillon, Lori Jacobi, Rene Nunez, James C. Norton, Victor Abler> ;Journal of Parkinson's Disease. 2020 Jan 1
158 Open-label Study of Pimavanserin Patients with Comorbid Parkinson's Disease and Depression.
Michael T. Guskey, Gustavo Alva, Jason L. Aldred, Bruce Coate, Daryl DeKarske, Marc Cantillon, James C. Norton> ;Cns Spectrums. 2020 Apr 1
17 citations
Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients.
Lucas R. Sass, Mohammadreza Khani, Jacob Romm, Marianne Schmid Daners, Kyle McCain, Tavara Freeman, Gregory T. Carter, Douglas L. Weeks, Brian Petersen, Jason Aldred, ...> ;Fluids and Barriers of the CNS. 2020 Jan 21
107 citations
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.
Miroslaw Brys, Laura Fanning, Serena Hung, Aaron Ellenbogen, Natalia Penner, Minhua Yang, Mackenzie Welch, Erica Koenig, Eric David, Tara Fox, Shavy Makh, Jason Aldred...> ;Movement Disorders. 2019 Aug 1
2 citations
Deep Brain Stimulation Generator Replacement in End-Stage Parkinson Disease.
Jonathan Dennis Carlson, Meghan Palmer, Aiden Hoefer, Emily J Cox, Pam McLeod, Jamie Mark, Jason Aldred> ;World Neurosurgery. 2019 May 3
1 citations
Reply to: DUOPA® is an Excellent Alternative Treatment but with Some Caveats.
Michelle A. Burack, Jason Aldred, Cindy Zadikoff, Arvydas Vanagunas, Kevin Klos, Bahri Bilir, Hubert H. Fernandez, David G. Standaert> ;Movement Disorders Clinical Practice. 2019 Apr 1
18 citations
Implementing Levodopa‐Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners
Michelle A. Burack, Jason Aldred, Cindy Zadikoff, Arvydas Vanagunas, Kevin Klos, Bahri Bilir, Hubert H. Fernandez, David G. Standaert> ;Movement Disorders Clinical Practice. 2018 Jul 1
134 citations
National randomized controlled trial of virtual house calls for Parkinson disease.
Christopher A. Beck, Denise B. Beran, Kevin M. Biglan, Cynthia M. Boyd, E. Ray Dorsey, Peter Schmidt, Richard Simone, Allison W. Willis, Nicholas B. Galifianakis, Maya...> ;Neurology. 2017 Sep 12
35 citations
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers
E. Ray Dorsey, Meredith A. Achey, Christopher A. Beck, Denise B. Beran, Kevin M. Biglan, Cynthia M. Boyd, Peter Schmidt, Richard Simone, Allison W. Willis, Nicholas B....> ;Telemedicine Journal and e-Health. 2016 Jul 1
12 citations
Post-traumatic shoulder movement disorders: A challenging differential diagnosis between organic and functional.
DM Sanjay Pandey Md, Fatta B. Nahab, Jason Aldred, John G. Nutt, Mark Hallett> ;Movement Disorders Clinical Practice. 2014 Jun 1
116 citations
The past, present, and future of telemedicine for Parkinson's disease.
Meredith A. Achey, Jason Aldred, Noha Aljehani, Bastiaan R. Bloem, Kevin M. Biglan, Piu Chan, Esther Cubo, E. Ray Dorsey, Christopher G. Goetz, Mark Guttman, Anhar Has...> ;Movement Disorders. 2014 Jun 1
23 citations
Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease.
Lissa Brod, Jason L. Aldred, John G. Nutt> ;Movement Disorders. 2012 May 1
23 citations
Histopathology and computed tomography of age-associated degeneration of the equine temporohyoid joint.
R. J. Naylor, Justin Perkins, S P Allen, J Aldred, Edward R. C. Draper, Janet C. Patterson-Kane, Richard J. Piercy> ;Equine Veterinary Journal. 2010 Jul 1
Join now to see all

Journal Articles

The past, present, and future of telemedicine for Parkinson's disease
Achey, M, Aldred, JL et al., Movement Disoders, 6/29/2014
Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease
Aldred JL, Brod LS, Nutt JG, Movement Disorders, 5/2012

Books/Book Chapters

Encyclopedia of Movement Disorders
Chapter: Levodopa.
Page 132 - 137Aldred, J. and Nutt, J.Editors: K. Kompoliti and L. Verhagen.Associated Press2010

Abstracts/Posters

Levodopa-Carbidopa Intestinal Gel for the Treatment of Motor Fluctuations and Dyskinesia in Patients with Advanced Parkinson's Disease in a Real World Setting: Results...
Standaert, D, Aldred, J et. al, XXIV World Congress of Neurology, Dubai, UAE, 7/2019
Open Label Study of Pimavanserin in Patients with Comorbid Parkinson's Disease and Depression.
Guskey, M, Aldred, J et al., Neuroscience Education Institute Congress, Colorado Springs, CO, USA, 2019
Medication Use and In-Hospital Complications for Patients with Parkinson’s disease: A Retrospective Review. (Poster Presentation)
Kerndt, T, Aldred J, et al., World Parkinson Congress, Montreal, Canada, 1/1/2013
Hyperkinetic shoulder movement disorder associated with Ehlers-Danlos Syndrome. (Abstract)
American Academy of Neurology Meeting, 1/1/2009
Writer’s cramp, hemidystonia and ataxia secondary to pontomedullary tumor. (Abstract)
Movement Disorders Society International Congress, 1/1/2008
Efficacy of donepezil for tic reduction. (Abstract)
Movement Disorders Society International Congress, 1/1/2008
Join now to see all

Lectures

DBS Update
La Crosse, WI - 1/1/2013
Advances in Parkinson’s Care and Treatment
Wisconsin Dells, WI - 1/1/2013
Second Annual Parkinson’s Symposium
La Crosse, WI - 1/1/2012
Understanding Gait in Parkinson’s Disease
1/1/2012
“Update on Dystonia and Movement Disorders”
La Crosse, WI - 1/1/2012
“Patient with Limited Response to Previous Toxin Therapies”
La Crosse, WI - 1/1/2012
Parkinson’s Disease Update
Black River Falls, WI - 1/1/2011
First Annual Parkinson’s Symposium
La Crosse, WI - 1/1/2011
Movement Disorders Presentation
1/1/2011
Parkinson’s Disease Research Update
1/1/2010
Essential Tremor Patient Symposium
Gundersen Lutheran Medical Center, La Crosse, WI - 1/1/2010
Parkinson’s Disease Update
Decorah, IA - 1/1/2010
“Shaking Up Parkinson’s Disease”
Tomah, WI - 1/1/2010
“Early Diagnosis and Treatment of Parkinson’s Disease - A Continuing Pursuit”
Gundersen Lutheran Medical Center - 1/1/2010
“Movement Disorders”, Grand Rounds
Gundersen Lutheran Medical Center - 1/1/2010
“Cervical Dystonia”
1/1/2010
Research Update on Parkinson’s Disease
1/1/2008
Non-Motor Features of Parkinson’s Disease, presentation
1/1/2007
Update of Parkinson’s Disease Research for the Corvallis
1/1/2006
Spinal Cord Disease, presentation
1/1/2006
Neurotoxicology and Movement Disorders, presentation
1/1/2005
Join now to see all

Other

Concept and Development of Department of Neurology and Residency Program Website
Aldred JL, Oregon Health and Science Neurology Department
1/1/2005

Press Mentions

AbbVie Announces ABBV-951 (Foslevodopa/Foscarbidopa) Showed Improvement in Controlling Motor Fluctuations Compared to Oral Levodopa/Carbidopa Medication in Pivotal Phase 3 Trial in Patients with Advanced Parkinson's DiseaseOctober 28th, 2021
INW Research Grows Alongside Neurology ClinicFebruary 27th, 2020
Spokane-Based Inland Northwestern Research Offers Parkinson’s Disease Clinical Trials in SpokaneJuly 28th, 2019
Join now to see all